Promega Gets Patent Claims Invalidated In DNA Analysis Row
Promega Corp. can label its DNA fingerprinting products for forensic use, paternity testing, or research or clinical purposes, after a federal judge on Wednesday invalidated claims in a patent asserted by...To view the full article, register now.
Already a subscriber? Click here to view full article